Background/Aims: in various cardiovascular diseases. Numerous studies have demonstrated that microRNAs that miR-150 is downregulated in cardiovascular diseases, such as acute myocardial infarction in these pathological processes remains unknown. Methods: We used the transverse aortic we used both miR-150 knockout mice and wild type (WT) mice in the TAC model. Changes in cardiac function and pathology were measured using transthoracic echocardiography and pathological analysis, respectively. Furthermore, we predicted the target of miR-150 in in vitro CF transfection experiments using miR-150 analogs and siRNA corresponding to the predicted target. Results: We observed decreased expression levels of miR-150 in hearts suffering pressure overload, and these levels decreased more sharply in CFs than in cardiomyocytes. In addition, the degrees of cardiac function mice. By transfecting CFs with an miR-150 analog in vitro, we observed that miR-150 inhibited
MicroRNA-150 Inhibits the Activation of Cardiac Fibroblasts by Regulating c-Myb

